Serial 88063005
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 10 Oct 2025)
What this means for you
Registered since 19 May 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88063005
- Registration number
- 6059422
- Mark type
- Design / logo
- Filed
- 02 Aug 2018
- Published for opposition
- 25 Dec 2018
- Registered
- 19 May 2020
- Attorney of record
- Douglas A. Rettew
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological disorders
Owner
- Biogen MA Inc., Cambridge, MA, US
- Biogen MA Inc., Cambridge, MA, US
- Biogen MA Inc., Cambridge, MA, US
Prosecution history
- 10 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 10 Oct 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 10 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Jun 2025 — TEAS SECTION 8 & 15 RECEIVED
- 19 May 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 May 2020 — REGISTERED-PRINCIPAL REGISTER
- 17 Apr 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Apr 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Apr 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Apr 2020 — USE AMENDMENT FILED
- 08 Apr 2020 — TEAS STATEMENT OF USE RECEIVED
- 26 Mar 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Mar 2020 — SOU EXTENSION 2 GRANTED
- 19 Feb 2020 — SOU EXTENSION 2 FILED
- 25 Mar 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL